Tag: HPV

Inovio Pharmaceuticals Stock Up By 28% In The Last 21 Sessions

(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) rose by a staggering 28.66% in 21 sessions from $1.64 at 2022-10-20, to $2.11 at 14:28 EST on Friday, after two sequential sessions in a row of losses. NASDAQ is falling 0.39% to $11,101.66, after two successive sessions in a row of…

Continue Reading Inovio Pharmaceuticals Stock Up By 28% In The Last 21 Sessions

Inovio Pharmaceuticals Stock Up Momentum With A 31% Rise In The Last 21 Sessions

(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) rose by a staggering 31.69% in 21 sessions from $1.83 at 2022-10-17, to $2.41 at 11:43 EST on Monday, following the last session’s downward trend. NASDAQ is falling 0.67% to $11,247.78, after two successive sessions in a row of gains. Inovio Pharmaceuticals’s…

Continue Reading Inovio Pharmaceuticals Stock Up Momentum With A 31% Rise In The Last 21 Sessions

Inovio Pharmaceuticals Stock Is 9% Up Today

(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) rose 9.15% to $1.79 at 16:14 EST on Friday, after four sequential sessions in a row of losses. NASDAQ is jumping 1.89% to $10,815.92, after two consecutive sessions in a row of losses. This seems, up until now, an all-around positive trend…

Continue Reading Inovio Pharmaceuticals Stock Is 9% Up Today

Inovio Pharmaceuticals Stock Was Up By 17.31% Today

(VIANEWS) – The NASDAQ ended the session with Inovio Pharmaceuticals (INO) rising 17.31% to $1.83 on Thursday while NASDAQ fell 0% to $0.00. Inovio Pharmaceuticals’s last close was $1.66, 78.64% under its 52-week high of $7.77. About Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. is a biotechnology firm that focuses on developing,…

Continue Reading Inovio Pharmaceuticals Stock Was Up By 17.31% Today

Scientists develop more accurate predictive test for cervical cancer

The test can also pick up DNA markers for some other cancers, meaning it could in future be used as a predictive test for breast, womb, cervical and ovarian cancer. When tested for cervical cancer, it performed better than currently available methods for detecting those with advanced cell changes who…

Continue Reading Scientists develop more accurate predictive test for cervical cancer

More accurate test for cervical cancer ‘great news’, say campaigners

A more accurate test for cell changes that could lead to cervical cancer has been developed by scientists. The test can also pick up DNA markers for some other cancers, meaning it could in future be used as a predictive test for breast, womb, cervical and ovarian cancer. When tested…

Continue Reading More accurate test for cervical cancer ‘great news’, say campaigners

A novel causative functional mutation in GATA6 gene is responsible for familial dilated cardiomyopathy as supported by in silico functional analysis

Pérez-Serra, A. et al. Genetic basis of dilated cardiomyopathy. Int. J. Cardiol. 224, 461–472 (2016). PubMed  Article  Google Scholar  Petropoulou, E. et al. Digenic inheritance of mutations in the cardiac troponin (TNNT2) and cardiac beta myosin heavy chain (MYH7) as the cause of severe dilated cardiomyopathy. Eur. J. Med. Genet….

Continue Reading A novel causative functional mutation in GATA6 gene is responsible for familial dilated cardiomyopathy as supported by in silico functional analysis

Do preteens really need an HPV vaccine?

by Dr. Rebekah Fenton and Dr. Rebecca Perkins Gardasil vaccine and box. Image: Wikipedia Q: Why is it important for my 10-year-old to get the HPV vaccine? A: If you are the parent of a preteen who is between the ages of 9 and 12, it’s time to make sure…

Continue Reading Do preteens really need an HPV vaccine?

Using CRISPR/Cas to develop biosafety materials

The diagnosis and treatment of viral infections, especially those that cause large-scale outbreaks, is urgently needed, as the lack of these measures allows epidemics to progress. A new Biosafety and Health study discusses the use of the highly efficient clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas) technology to…

Continue Reading Using CRISPR/Cas to develop biosafety materials

Optimization of cerebrospinal fluid microbial DNA metagenomic sequencing diagnostics

We implemented a metagenomic DNA sequencing methodology to unbiasedly detect microbial species in CSF samples from patients with CNS symptoms in which a pathogen or EBV had been detected (Additional 3: Table 1). Samples positively identified with pathogen-specific quantitative PCR (qPCR), 16S rRNA gene sequencing or bacterial/mycotic culture in CSF…

Continue Reading Optimization of cerebrospinal fluid microbial DNA metagenomic sequencing diagnostics

Phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein PINLYP regulates type I interferon innate immunity

Significance Interferon (IFN)-mediated antiviral responses serve as the first line of the host innate immune defense against viral infection. Here we identify a previously uncharacterized protein designated phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein (PINLYP), which is essential for embryonic development and plays an important role in type I IFN…

Continue Reading Phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein PINLYP regulates type I interferon innate immunity

CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Nucleic acid analysis using ultrasensitive and simple methods is critically important for the early-stage diagnosis and treatment of diseases. The CRISPR/Cas proteins, guided by a single-stranded RNA have shown incredible capability for sequence-specific targeting and detection. Herein, in order to improve and expand the application of CRISPR/Cas technology to the…

Continue Reading CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

BioChain announces expanded line of NGS characterized bio-samples for oncology researchers

NEWARK, Calif., Sept. 22, 2021 /PRNewswire/ — BioChain Institute, (“BioChain”), a leader in high quality processed bio-sample products, announced an expanded line of Next Generation Sequencing (NGS) characterized bio-samples encompassing a variety of cancer-related mutations available for preclinical drug development and as reference samples for CLIA labs.  “Scientists are looking for…

Continue Reading BioChain announces expanded line of NGS characterized bio-samples for oncology researchers

Genotype distribution and prevalence of human papillomavirus

Introduction Cervical cancer (CC) is the second most deadly disease among women in the world and is the leading cause of death from cancer.1 In 2018, there were 570,000 new diseases and 311,000 deaths worldwide.2 Viral infections contribute to 15–20% of all cancers, and several viruses play an important role…

Continue Reading Genotype distribution and prevalence of human papillomavirus

National Health Commission responds on concerns about a third dose for people with high risk

Is it necessary to take the COVID-19 booster dose and are there any suggestions on traveling during the upcoming Mid-Autumn Festival and National Day holidays? These are some of the questions that are being raised currently. Here are the answers from the National Health Commission, which held a press conference…

Continue Reading National Health Commission responds on concerns about a third dose for people with high risk

Answers to commonly asked questions, KNEWS

As of July 2021, the coronavirus vaccine has been added to the National Vaccination Program for children and adolescents aged 12-17. Here are the most commonly asked questions and answers about the COVID-19 vaccine provided by the National Vaccination Committee. I hesitate to vaccinate my child because these vaccines…

Continue Reading Answers to commonly asked questions, KNEWS